Thursday, October 23, 2008

Teva Introduces Fentanyl Transdermal System, CII

October 23, 2008 – Teva Pharmaceuticals is pleased to announce the FDA approval of Fentanyl Transdermal System, CII, 25 mcg, 50 mcg, 75 mcg and 100 mcg. This product is AB rated and bioequivalent to Duragesic®* Transdermal System. Fentanyl Transdermal System is available in cartons containing 5 patches each.

The details can be read here.

No comments: